SWSteven Woloshin

Steven Woloshin

*This is an algorithmically generated author record based on publicly available information.

Steven Woloshin has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Lisa M. Schwartz

    The Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire

    13 shared publications
  • Lisa M. Schwartz

    Dartmouth Institute for Health Policy and Clinical Practice, The C. Everett Koop Institute at Dartmouth, The Lisa Schwartz Foundation, Lebanon, NH 03766, USA

    12 shared publications
  • H. Gilbert Welch

    From the Veterans Affairs Outcomes Group, White River Junction, Vermont, and the Center for Medicine in the Media at the Dartmouth Institute for Health Policy and Clinical Practice, Hanover, New Hampshire

    7 shared publications
  • Lisa M Schwartz

    VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT 05009, USA

    7 shared publications
  • H. Gilbert Welch

    Center for Surgery and Public Health, Brigham and Women’s Hospital, Boston, Massachusetts

    4 shared publications
  • Barnett S. Kramer

    Member, The Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont, USA

    3 shared publications

Latest Publications

  • Patient- and Physician-Identified Considerations for Clinical Implementation of a New Risk-Based Prediction Tool to Guide Surveillance Mammography in Breast Cancer Survivors

    by Christine M. Gunn, Nancy Boyer, Sidra Sheikh, Janie M. Lee, Steven Woloshin, Jennifer M. Specht, Rebecca A. Hubbard, Erin J. Aiello Bowles, Anna N. A. Tosteson

    PURPOSE: Patient, tumor, and treatment factors can help predict the chance that a woman with a history of breast cancer diagnosis will be diagnosed with a second breast cancer within a year of a negative mammogram. This qualitative study elucidates breast cancer survivor and multispecialty physician perspectives on barriers/facilitators to clinical implementation of a risk-prediction tool to support surveillance decisions. MATERIALS AND METHODS: We enrolled women who completed primary breast cancer treatment and physicians from November 2023 to April 2024. Participants were recruited through Breast Cancer Surveillance Consortium's registries; patients participated in one of four focus groups and physicians participated in individual semistructured interviews. Participants were presented with information about an interval cancer risk prediction tool and were prompted to share perspectives on facilitators and barriers to using such a tool. To identify salient themes, thematic analysis was undertaken by three research team members. RESULTS: Participants included 40 physicians and 23 patients. Three themes emerged: (1) evidence needed for tool acceptance, (2) tool features to facilitate usage, and (3) barriers to tool adoption. Both cancer survivor and physician groups were accepting of risk prediction tool use for surveillance imaging when tool development information was available; they perceived the tool would fit within workflows, and data integrity could be verified. Both groups anticipated structural (time) and technological barriers (magnetic resonance imaging availability) could impede adoption. CONCLUSION: Qualitative findings from focus groups and interviews analyzed thematically suggest implementing a risk prediction tool for surveillance imaging requires evidence transparency, health record integration, data integrity protection, and system supports to promote ease of use in clinical settings while mitigating unintended consequences. All are important to consider during tool development and implementation planning.

  • Open Access

    Comparison of AI-assisted and human-generated plain language summaries for Cochrane reviews: a randomised non-inferiority trial (HIET-1) [Registered Report - stage II]

    by Declan Devane, Johanna Pope, Paula Byrne, Evan Forde, Isabel O'BYrne, Steven Woloshin, Eileen Culloty, Darren Dahly, Ingeborg Hess Elgersma, Heather Munthe-Kaas, et al.


  • Open Access

    Comparison of AI-assisted and human-generated plain language summaries for Cochrane reviews: protocol for a randomised trial (HIET-1) [Registered Report - stage I]

    by Declan Devane, Johanna Pope, Paula Byrne, Evan Forde, Steven Woloshin, Eileen Culloty, Darren Dahly, Ingeborg Hess Elgersma, Heather Munthe-Kaas, Conor Judge, et al.


  • Open Access

    Alternative Presentations of Overall and Statistical Uncertainty for Adults’ Understanding of the Results of a Randomized Trial of a Public Health Intervention: Parallel Web-Based Randomized Trials

    by Christine Holst, Steven Woloshin, Andrew D Oxman, Christopher Rose, Sarah Rosenbaum, Heather Menzies Munthe-Kaas

    Background: Well-designed public health messages can help people make informed choices, while poorly designed messages or persuasive messages can confuse, lead to poorly informed decisions, and diminish trust in health authorities and research. Communicating uncertainties to the public about the results of health research is challenging, necessitating research on effective ways to disseminate this important aspect of randomized trials. Objective: This study aimed to evaluate people’s understanding of overall and statistical uncertainty when presented with alternative ways of expressing randomized trial results. Methods: Two parallel, web-based, individually randomized trials (3×2 factorial designs) were conducted in the United States and Norway. Participants were randomized to 1 of 6 versions of a text (summary) communicating results from a study examining the effects of wearing glasses to prevent COVID-19 infection. The summaries varied in how overall uncertainty (“Grading of Recommendations Assessment, Development and Evaluation [GRADE] language,” “plain language,” or “no explicit language”) and statistical uncertainty (whether a margin of error was shown or not) were presented. Participants completed a web-based questionnaire exploring 4 coprimary outcomes: 3 to measure understanding of overall uncertainty (benefits, harms, and sufficiency of evidence), and one to measure statistical uncertainty. Participants were adults who do not wear glasses recruited from web-based research panels in the United States and Norway. Results of the trials were analyzed separately and combined in a meta-analysis. Results: In the US and Norwegian trials, 730 and 497 individuals were randomized, respectively; data for 543 (74.4%) and 452 (90.9%) were analyzed. More participants had a correct understanding of uncertainty when presented with plain language (United States: 37/99, 37% and Norway: 40/76, 53%) than no explicit language (United States: 18/86, 21% and Norway: 34/80, 42%). Similar positive effect was seen for the GRADE language in the United States (26/79, 33%) but not in Norway (30/71, 42%). There were only small differences between groups for understanding the uncertainty of harms. Plain language improved correct understanding of evidence sufficiency (odds ratio 2.05, 95% CI 1.17-3.57), compared to no explicit language. The effect of GRADE language was inconclusive (odds ratio 1.34, 95% CI 0.79-2.28). The understanding of statistical uncertainty was improved when the participants were shown the margin of error compared to not being shown: Norway: 16/75, 21% to 24/71, 34% vs 1/71, 1% to 2/76, 3% and the United States: 21/101, 21% to 32/90, 36% vs 0/86, 0% to 3/79, 4%). Conclusions: Plain language, but not GRADE language, was better than no explicit language in helping people understand overall uncertainty of benefits and harms. Reporting margin of error improved understanding of statistical uncertainty around the effect of wearing glasses, but only for a minority of participants. Trial Registration: ClinicalTrials.gov NCT05642754; https://tinyurl.com/4mhjsm7s


  • Open Access

    Alternative Presentations of Overall and Statistical Uncertainty for Adults’ Understanding of the Results of a Randomized Trial of a Public Health Intervention: Parallel Web-Based Randomized Trials (Preprint)

    by Christine Holst, Steven Woloshin, Andrew D Oxman, Christopher Rose, Sarah Rosenbaum, Heather Menzies Munthe-Kaas

    BACKGROUND Well-designed public health messages can help people make informed choices, while poorly designed messages or persuasive messages can confuse, lead to poorly informed decisions, and diminish trust in health authorities and research. Communicating uncertainties to the public about the results of health research is challenging, necessitating research on effective ways to disseminate this important aspect of randomized trials. OBJECTIVE This study aimed to evaluate people’s understanding of overall and statistical uncertainty when presented with alternative ways of expressing randomized trial results. METHODS Two parallel, web-based, individually randomized trials (3×2 factorial designs) were conducted in the United States and Norway. Participants were randomized to 1 of 6 versions of a text (summary) communicating results from a study examining the effects of wearing glasses to prevent COVID-19 infection. The summaries varied in how overall uncertainty (“Grading of Recommendations Assessment, Development and Evaluation [GRADE] language,” “plain language,” or “no explicit language”) and statistical uncertainty (whether a margin of error was shown or not) were presented. Participants completed a web-based questionnaire exploring 4 coprimary outcomes: 3 to measure understanding of overall uncertainty (benefits, harms, and sufficiency of evidence), and one to measure statistical uncertainty. Participants were adults who do not wear glasses recruited from web-based research panels in the United States and Norway. Results of the trials were analyzed separately and combined in a meta-analysis. RESULTS In the US and Norwegian trials, 730 and 497 individuals were randomized, respectively; data for 543 (74.4%) and 452 (90.9%) were analyzed. More participants had a correct understanding of uncertainty when presented with plain language (United States: 37/99, 37% and Norway: 40/76, 53%) than no explicit language (United States: 18/86, 21% and Norway: 34/80, 42%). Similar positive effect was seen for the GRADE language in the United States (26/79, 33%) but not in Norway (30/71, 42%). There were only small differences between groups for understanding the uncertainty of harms. Plain language improved correct understanding of evidence sufficiency (odds ratio 2.05, 95% CI 1.17-3.57), compared to no explicit language. The effect of GRADE language was inconclusive (odds ratio 1.34, 95% CI 0.79-2.28). The understanding of statistical uncertainty was improved when the participants were shown the margin of error compared to not being shown: Norway: 16/75, 21% to 24/71, 34% vs 1/71, 1% to 2/76, 3% and the United States: 21/101, 21% to 32/90, 36% vs 0/86, 0% to 3/79, 4%). CONCLUSIONS Plain language, but not GRADE language, was better than no explicit language in helping people understand overall uncertainty of benefits and harms. Reporting margin of error improved understanding of statistical uncertainty around the effect of wearing glasses, but only for a minority of participants. CLINICALTRIAL ClinicalTrials.gov NCT05642754; https://tinyurl.com/4mhjsm7s

  • The New USPSTF Mammography Recommendations — A Dissenting View

    by Steven Woloshin, Karsten Juhl Jørgensen, Shelley Hwang, H. Gilbert Welch


  • Open Access

    Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates

    by Steven Woloshin, Victoria Landsman, Daniel G. Miller, Jeffrey Byrne, Barry I. Graubard, Eric J. Feuer

    Importance: To make wise decisions about the health risks they face, people need information about the magnitude of the threats as well as the context, such as how risks compare. Such information is often presented by age, sex, and race but rarely accounts for smoking status, a major risk factor for many causes of death.Objective: To update the National Cancer Institute’s Know Your Chances website to present mortality estimates for a broad set of causes of death and all causes combined by smoking status in addition to age, sex, and race.Design, Setting, and Participants: In this cohort study, mortality estimates using life table methods were calculated with the National Cancer Institute’s DevCan software package, combining data from the US National Vital Statistics System, National Health Interview Survey–Linked Mortality Files, National Institutes of Health–AARP (American Association of Retired Persons), Cancer Prevention Study II, Nurses’ Health and Health Professions follow-up studies, and Women’s Health Initiative. Data were collected from January 1, 2009, to December 31, 2018, and analyzed from August 27, 2019, to February 28, 2023.Main Outcomes and Measures: Age-conditional probabilities of dying due to various causes and all causes combined, accounting for competing causes of death, for people aged 20 to 75 years over the next 5, 10, or 20 years by sex, race, and smoking status.Results: A total of 954 029 individuals aged 55 years or older (55.8% women) were included in the analysis. Regardless of sex or race, for never-smokers, coronary heart disease represented the highest 10-year chance of death after about 50 years of age, which is higher than for any malignant neoplasm. Among current smokers, the 10-year chance of death due to lung cancer was almost as high as for coronary heart disease in each group. For Black and White female current smokers aged from the mid-40s onward, the 10-year probability of death due to lung cancer was substantially higher than for breast cancer. After 40 years of age, the observed effect of never vs current smoking on the 10-year chance of death due to all causes approximated adding 10 years of age. After 40 years of age when conditioning on smoking status, mortality risk for Black individuals was approximately that of White individuals 5 years older.Conclusions and Relevance: Using life table methods and accounting for competing risks, the revised Know Your Chances website presents age-conditional mortality estimates according to smoking status for a broad set of causes in the context of other conditions and all-cause mortality. The findings of this cohort study suggest that failing to account for smoking status results in inaccurate mortality estimates for many causes—namely, they are too low for smokers and too high for nonsmokers.


  • Communicating health information with visual displays

    by Steven Woloshin, Yanran Yang, Baruch Fischhoff

    Well-designed visual displays have the power to convey health messages in clear, effective ways to non-experts, including journalists, patients and policymakers. Poorly designed visual displays, however, can confuse and alienate recipients, undermining health messages. In this Perspective, we propose a structured framework for effective visual communication of health information, using case examples of three common communication tasks: comparing treatment options, interpreting test results, and evaluating risk scenarios. We also show simple, practical ways to evaluate a design’s success and guide improvements. The proposed framework is grounded in research on health risk communication, visualization and decision science, as well as our experience in communicating health data.


  • Open Access

    Cancer overdiagnosis: A challenge in the era of screening

    by Barbara K. Dunn, Steven Woloshin, Heng Xie, Barnett S. Kramer


  • The Increasing Incidence of Early-Onset Colorectal Cancer

    by Steven Woloshin, Barnett S Kramer

    To the Editor: Graphs help to uncover patterns in data. Ideally, they clarify information, but they can also be misused and misleading. In his classic text, How to Lie with Statistics, Darrell Huff explained how graphical shenanigans can bias rather than inform reader perceptions.1 Such a graph recently appeared in the Journal, in the Review Article by Sinicrope (April 21 issue) (see